Siglec15 facilitates the progression of non-small cell lung cancer and is correlated with spinal metastasis

BACKGROUND: Non-small cell lung cancer (NSCLC) frequently metastasizes to bone, leading to poor prognosis. Siglec15 has been identified as a newly discovered immune checkpoint and exists in a variety of tumors. However, the expression and function of Siglec15 in NSCLC and bone metastasis remains lar...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Haifeng, Chen, Qing, Hu, Zhichao, Zhou, Lei, Meng, Qingbing, Zhang, Taiwei, Wang, Ben, Ge, Yuxiang, Lu, Shunyi, Ding, Wang, Zhou, Xiaogang, Li, Xilei, Lin, Hong, Jiang, Libo, Dong, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011207/
https://www.ncbi.nlm.nih.gov/pubmed/35434017
http://dx.doi.org/10.21037/atm-22-764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011207/
https://www.ncbi.nlm.nih.gov/pubmed/35434017
http://dx.doi.org/10.21037/atm-22-764

Ejemplares similares